| Name of Section - Pelvic Floor Stimulation
as a Treatment of Urinary Incontinence
| Topic: Pelvic Floor Stimulation
as a Treatment of Urinary Incontinence |
Date of Origin: 01/1996 |
| Section: Allied Health |
Policy No: 4 |
| Approved Date: 12/30/2008 |
Effective Date: 01/01/2009 |
| Next Review Date: 01/2010 |
IMPORTANT REMINDER
Regence Medical Policies are developed to provide guidance for members and providers regarding
coverage in accordance with contract terms. Benefit determinations are based in all cases on
the applicable contract language. To the extent there may be any conflict between the Medical
Policy and contract language, the contract language takes precedence.
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that
are considered investigational or cosmetic. Providers may bill members for services or
procedures that are considered investigational or cosmetic. Providers are encouraged to inform
members before rendering such services that the members are likely to be financially responsible
for the cost of these services.
Description
A variety of non-surgical approaches have been investigated
as treatments of urinary incontinence, including pelvic
floor muscle exercises (PME), biofeedback, other behavioral
therapies, and pelvic floor stimulation. Pelvic floor
stimulation (PFS) involves the electrical stimulation
of pelvic floor muscles using either a probe wired
to a device for controlling the electrical stimulation,
or more recently, extracorporeal pulsed magnetic innervation.
It is thought that pelvic floor stimulation of the
pudendal nerve will improve urethral closure by activating
the pelvic floor musculature. In addition, PFS is thought
to improve partially denervated urethral and pelvic
floor musculature by enhancing the process of reinnervation.
The methods of PFS have varied in location (vaginal,
rectal), stimulus frequency, stimulus intensity or
amplitude, pulse duration, pulse to rest ratio, treatments
per day, number of treatment days per week, length
of time for each treatment session, and overall time
period for device use between clinical and home settings.
Variation in the amplitude and frequency of the electrical
pulse is used to mimic and stimulate the different
physiologic mechanisms of the voiding response, depending
on the type of etiology of incontinence, e.g., either
detrusor instability, stress incontinence, or a mixed
pattern. Magnetic pelvic floor stimulation does not
require an internal electrode; patients may sit, fully
clothed, on a specialized chair.
Patients receiving PFS may undergo treatments in a
physician’s office or physical therapy facility,
or patients may undergo initial training in a physician’s
office followed by home treatment with a rented or
purchased pelvic floor stimulator. Magnetic PFS is
delivered in the physician's office.
Note: Stimulation of the sacral nerve as a treatment
of incontinence is discussed separately in Surgery,
Policy No. 134.
Policy/Criteria
Electrical or magnetic stimulation of the pelvic
floor muscles (pelvic floor stimulation) as a treatment
for urinary incontinence is considered investigational.
Scientific Background
Electrical Pelvic Floor Stimulation
The policy regarding electrical pelvic floor stimulation
is based on a 2000 BlueCross BlueShield Association
Technology Evaluation Center (TEC) assessment that
reviewed the published peer-reviewed literature focusing
on the safety and effectiveness of electrical pelvic
floor stimulation compared to placebo and compared
to other forms of behavioral therapies, including pelvic
floor muscle exercises and the use of vaginal cones.
(2) The specific etiologies of stress incontinence,
urge incontinence, and post-prostatectomy incontinence
were considered. The assessment offered the following
conclusions:
- Eleven controlled trials, of which all but one
were randomized, reported outcomes of pelvic floor
stimulation in the treatment of stress incontinence.
These trials do not provide strong and consistent
evidence that pelvic floor stimulation reduces the
frequency and severity of incontinent episodes.
- Two randomized controlled trials investigated
pelvic floor stimulation in women with urge or mixed
incontinence. No conclusions can be drawn from either
trial. One 1997 trial did not report the key clinical
outcomes, i.e., improvement and cure as measured
by voiding diaries or pad testing. The second trial
found no significant difference between pelvic floor
stimulation and the sham treatment arm.
- One randomized trial focused on pelvic floor stimulation
for men with persistent post-prostatectomy incontinence.
There was no significant difference in results between
the patients receiving pelvic floor stimulation plus
pelvic muscle exercises compared to those undergoing
muscle exercises alone.
Since publication of the TEC Assessment, several additional
published studies investigated the use of electrical
pelvic floor stimulation in patients with stress incontinence,
but none provided evidence supporting a beneficial
effect for this diagnosis. Specifically, one small,
randomized double-blind study of 27 patients compared
a new pattern of electrical stimulation with sham stimulation.
(3) The electrical stimulation group showed statistically
greater improvement on the quality of life measure,
but no between-group differences were observed in other
outcome parameters, including pad testing. A second
randomized trial of 60 women compared the effectiveness
of electrical stimulation plus biofeedback with pelvic
floor exercise. (4) The electrical stimulation-biofeedback
group performed better than the pelvic floor exercise
group. However, the paper did not report key clinical
outcomes, e.g., improvement and cure as measured by
voiding diaries or pad testing. More importantly, due
to the combined therapy of electrical stimulation and
biofeedback, the independent effect of electrical stimulation
was not evaluated. In another randomized trial, Goode
and colleagues reported the outcomes of a trial that
randomized 200 women with primary stress incontinence
to undergo either 8 weeks of behavioral training, 8
weeks of behavioral training plus home pelvic floor
stimulation, or self-administered behavioral training
alone using a self-help booklet. (5) The main outcomes
measurements were the results of bladder diaries and
changes in quality of life. Patients in all 3 groups
reported significant improvements in incontinence;
there were no significant differences between the groups.
One double-blind randomized controlled study compared
the effects of electrical stimulation with sham treatment
in 68 patients with urge incontinence due to detrusor
overactivity. (6) Reported outcomes suggested a beneficial
treatment effect with electrical stimulation. Based
on patient diaries, 19% of patients receiving active
treatment versus 3% of patients receiving sham treatment
were cured, while 81% of active patients versus 32%
of sham patients were improved. These differences were
statistically significant. The study did not report
the more objective pad testing, and given the inconclusive
or conflicting results reported in two earlier studies,
additional evidence is needed from well-designed trials
to determine the benefits of electrical stimulation
for urge incontinence. Wang and colleagues compared
the outcomes of a 12-week program of pelvic floor muscle
training, biofeedback-assisted pelvic floor muscle
training, and electrical stimulation in a randomized
study of in a group of 103 women with “over active
bladder,”
primarily due to urge incontinence. (7) The biofeedback
consisted of an intravaginal electromyogram probe,
while an intravaginal electrode provided the electrical
stimulation. Treatment outcomes included results of
voiding diaries and quality of life measures, and urodynamic
measures. The authors report that both the biofeedback
and electrical stimulation groups reported an increased
incidence of resolution or improvement of incontinence,
but do not describe how this outcome was assessed.
There were significant changes in some domains of the
quality of life questionnaires in the biofeedback and
electrical stimulation group, and the improvement in
overall quality of life score was significantly better
for the electrical stimulation compared to the pelvic
floor exercise group. There were no significant differences
in the voiding diary scores, but the authors rejected
this outcome due to missing data in the diaries. Biofeedback
was associated with the greatest improvement in muscle
strengthening, but as noted above, muscle strength
is not considered a key clinical outcome. Pad testing,
the most objective outcome was not performed.
Spruijt and colleagues reported results from a randomized
trial involving women over age 65 with symptoms of
stress, urge or mixed urinary incontinence. (8) There
were no statistically significant differences between
patients treated with electrical stimulation versus
those treated with Kegel training only. In two separate
double-blind studies, symptoms were significantly reduced
in both groups following treatment. (9,21) There were
no significant between-group differences in outcomes.
Wille and colleagues randomized post-prostatectomy
patients to receive 1 of 3 treatments: pelvic muscle
exercises (PMEs), PMEs plus electrical stimulation,
or PMEs in conjunction with both electrical stimulation
and biofeedback. (10) Outcomes were evaluated
according to questionnaires and the more objective
pad test. There were no statistically significant
differences in continence rates between the three groups.
Magnetic Pelvic Floor Stimulation
A 2000 TEC Assessment evaluated the use of electromagnetic
pelvic floor stimulation. (11) At the time,
minimal data regarding these devices were available,
and no randomized trials had isolated and validated
the effectiveness of the treatment. (12,13) Galloway
and colleagues presented the results of a multicenter
prospective nonrandomized trial in 83 patients with
stress urinary incontinence. (14) Patients were
treated for 20 minutes twice a week for six weeks.
A total of 66% of patients were either dry or using
no more than one pad per day after a 3-month follow-up.
The TEC Assessment concluded that these preliminary
results require confirmation in randomized trials.
A study of 52 patients randomized to either active
or sham magnetic stimulation reported statistically
significant differences between baseline and post treatment
measures in the active functional magnetic stimulation
group. (15) However, p values were not reported for
comparisons between the placebo and treatment groups.
Thus, it is not possible to reach scientific conclusions
from this study concerning the effects of functional
magnetic stimulation on health outcomes. Another
randomized, double-blind, sham controlled study of
39 patients reported significant improvement between
baseline and post treatment measures in both the active
and sham groups at 24 weeks follow-up. (20) The between
group comparison was not statistically significant.
In addition to the above study, Galloway and colleagues
reported an update of the multicenter prospective nonrandomized
trial that included 111 women with stress urinary incontinence
who were treated with extracorporeal magnetic innervation.
(16) A total of 47 women completed 6-month follow-up
testing; 38 patients were completely dry or used less
than 1 pad per day (81%). Pad use was reduced in 33
patients (70%). Nevertheless, lacking a control group,
the influence of patient selection bias on these outcomes
cannot be ruled out.
Fujishiro and colleagues published the results of
a trial that enrolled 37 women with frequency or urge
incontinence to receive either true or placebo magnetic
stimulation. (17) Outcomes were assessed at 3
days and 1 week after treatment. The authors reported
the treatment group reported improvement in the urine
volume, number of leaks, and quality of life. However,
the short follow-up of 1 week precludes scientific
conclusions. Voorham-van der Zalm and colleagues
reported no significant difference in before and after
treatment outcomes in 74 patients who received eight
weeks of magnetic stimulation treatment. (18) Although
several other studies have been published, including
one comparative trial (19), none included a
placebo control; therefore, it is not possible to draw
scientific conclusions concerning the treatment effects
of magnetic stimulation on incontinence.
In summary, the evidence published to date is not
sufficient to demonstrate that electrical or magnetic
pelvic floor stimulation results in improved health
outcomes in patients with urinary incontinence when
compared to either sham devices or behavioral therapy.
An updated search of the MEDLINE database through February
10, 2008 failed to return any studies of electrical
or magnetic stimulation that alter the conclusions
reached above.
References
- BlueCross BlueShield Association Medical Policy
Reference Manual, Policy No. 1.01.17
- TEC Assessment: Pelvic Floor Stimulation in the
Treatment of Urinary Incontinence, 2000; BlueCross
and BlueShield Association Technology Evaluation
Center Vol 15, Tab 2
- Jeyaseelan SM, Haslam EJ, Winstanly J et al. An
evaluation of a new pattern of electrical stimulation
as a treatment for urinary stress incontinence: a
randomized, double-blind, controlled trial. Clin
Rehabil 2000;14(6):631-40
- Sung MS, Hong JY, Choi YH et al. FES-biofeedback
versus intensive pelvic floor muscle exercise for
the prevention and treatment of genuine stress incontinence.
J Korean Med Sci 2000;15(3):303-8
- Goode PS, Burgio KL, Locher JL, et al. Effect
of behavioral training with or without pelvic floor
electrical stimulation on stress incontinence in
women: a randomized controlled trial. JAMA 2003;290(3):345-52
- Yamanishi T, Yasuda K, Sakakibara R et al. Randomized,
double-blind study of electrical stimulation for
urinary incontinence due to detrusor overactivity. Urology 2000;55(3):353-7
- Wang AC, Wang YY, Chen MC. Single-blind, randomized
trial of pelvic floor muscle training, biofeedback-assisted
pelvic floor muscle training, and electrical stimulation
in the management of overactive bladder. Urology 2004:63(1):61-6
- Spruijt J, Vierhout M, Verstraeten R, Janssens
J, Burger C. Vaginal electrical stimulation of the
pelvic floor: a randomized feasibility study in urinary
incontinent elderly women. Acta Obstet Gynecol
Scand 2003;82(11):1043-8
- Amaro JL, Gameiro MO, Padovani CR, et al. Effect
of intravaginal electrical stimulation on pelvic
floor muscle strength. Int Urogynecol J Pelvic
Floor Dysfunct 2005;16(5):355-8
- Wille S, Sobottka A, Heidenreich A, Hofmann R.
Pelvic floor exercises, electrical stimulation and
biofeedback after radical prostatectomy: results
of a prospective randomized trial. J Urol 2003;170(2
Pt 1):490-3
- TEC Assessment: Magnetic Stimulation in the Treatment
of Urinary Incontinence in Adults, 2000; BlueCross
and BlueShield Association Technology Evaluation
Center Vol 15, Tab 8
- Yamanishi T, Yasuda K, Suda S et al. Effect of
functional continuous magnetic stimulation for urinary
incontinence. J Urol 2000;163(2):456-9
- Fujishiro T, Enomoto H, Ugawa Y et al. Magnetic
stimulation of the sacral roots for the treatment
of stress incontinence: an investigational study
and placebo controlled trial. J Urol 2000;164(4):1277-9
- Galloway NT, El-Gallery RE, Sand K et al. Extracorporeal
magnetic innervation therapy for stress urinary incontinence.
Urology 1999;53(6):1108-11
- But I. Conservative treatment of female urinary
incontinence with functional magnetic stimulation. Urology 2003;61(3):558-61
- Galloway NT, El-Gallery RE, Sand K. Update on
extracorporeal magnetic innervation (ExMI) therapy
for stress urinary incontinence. Urology 2000;56(6
suppl 1):82-6
- Fujishiro T, Takahashi S, Enomoto H et al. Magnetic
stimulation of the sacral roots for the treatment
of urinary frequency and urge incontinence: an investigational
study and placebo controlled trial. J Urol 2002;168(3):1036-9
- Voorham-van der Zalm PJ, Pelger RC, Stiggelbout
AM, et al. Effects of magnetic stimulation in the
treatment of pelvic floor dysfunction. BJU Int 2006;97(5):1035-8
- Yokoyama T, Nishiguchi J, Watanabe T. Comparative
study of effects of extracorporeal magnetic innervation
versus electrical stimulation for urinary incontinence
after radical prostatectomy. Urology 2004;63(2):264-7
- Suzuki T, Yasuda K, Yamanishi T, et al. Randomized,
double-blind, sham-controlled evaluation of the effect
of functional continuous magnetic stimulation in
patients with urgency incontinence. Neurourol
Urodyn 2007;26(6):767-72
- Amaro JL, Gamiero MO, Kawano PR, et al. Intravaginal
electrical stimulation: a randomized, double-blind
study on the treatment of missed urinary incontinence. Acta
Obstet Gynecol Scand 2006;85(5):619-22
Cross References
Sacral
Nerve Modulation/Stimulation for Pelvic Floor Dysfunction,
Regence Medical Policy Manual, Surgery Policy No.
134
| Codes |
Number |
Description |
| CPT |
0029T |
Treatment(s) for incontinence, pulsed magnetic
neuromodulation, per day (Deleted 1/1/09;
use 53899) |
| HCPCS |
E0740 |
Incontinence treatment system; pelvic floor stimulator,
monitor, sensor and/or trainer |
Name of Section Table of Contents 

|